Amarin | AMRN - Umlaufvermögen

Aktienkurs
14.53
Täglich Wechseln
0.03 0.21%
Monatlich
-0.75%
Jährlich
42.59%
Q2 Prognose
13.65




Umlaufvermögen Veränderung Datum
AbbVie USD 29.06B 523M 2025-12
Alnylam Pharmaceuticals USD 4.22B 168.65M 2026-03
Amarin USD 626.02M 23.87M 2026-03
AstraZeneca USD 29.61B 890M 2026-03
BioCryst Pharmaceuticals USD 404.35M 48.66M 2025-12
DBV Technologies USD 212.94M 124.06M 2025-12
Esperion Therapeutics USD 462.57M 102.11M 2025-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Neurocrine Biosciences USD 2.44B 86.6M 2026-03
Novartis USD 26.61B 3.85B 2026-03